Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-23 Option Award | 2024-05-28 4:10 pm | N/A 2034-05-22 | Vor Biopharma Inc. | VOR | Patterson Matthew R Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 6:33 pm | N/A 2033-06-14 | Homology Medicines Inc. | FIXX | Patterson Matthew R Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2023-05-26 Option Award | 2023-06-02 4:38 pm | N/A 2033-05-25 | Vor Biopharma Inc. | VOR | Patterson Matthew R Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:06 pm | N/A 2032-06-15 | Homology Medicines Inc. | FIXX | Patterson Matthew R Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:11 pm | N/A 2032-06-13 | Vor Biopharma Inc. | VOR | Patterson Matthew R Director | 16,911 | $0 | 16,911 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 5:40 pm | N/A 2031-06-17 | Homology Medicines Inc. | FIXX | Patterson Matthew R Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:16 pm | N/A 2031-02-04 | Vor Biopharma Inc. | VOR | Patterson Matthew R Director | 16,900 | $0 | 16,900 (Direct) | View |
Ownership | 2021-02-04 9:50 pm | N/A N/A | Vor Biopharma Inc. | VOR | Patterson Matthew R Director | 0 | $0 | 41,196 (Direct) | View |
| 2020-10-16 Other | 2020-10-20 8:56 pm | N/A N/A | 5:01 Acquisition Corp. | FVAM | Patterson Matthew R Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 5:27 pm | N/A 2030-06-10 | Homology Medicines Inc. | FIXX | Patterson Matthew R Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 433,272 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:35 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 734,353 | $0 | 0 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 64,751 | $0.78 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 162,538 | $0 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 11,666 | $15.26 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 74,297 | $2.19 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 11,824 | $9.5 | 765,175 (Direct) | View |
| 2019-12-26 Gift | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 12,500 | $0 | 765,175 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:16 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 1,974 | $59.21 | 283,234 (Direct) | View |